Atrial fibrillation medical therapy in patients presenting with ACS and/or PCI or valve intervention
Resident Survival Guide |
Atrial Fibrillation Microchapters | |
Special Groups | |
---|---|
Diagnosis | |
Treatment | |
Cardioversion | |
Anticoagulation | |
Surgery | |
Case Studies | |
Atrial fibrillation medical therapy in patients presenting with ACS and/or PCI or valve intervention On the Web | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rim Halaby, M.D. [2]
Overview
==2014 Management of Antithrombotic Therapy in AF Patients Presenting with ACS and/or Undergoing PCI or Valve Interventions: A Joint Consensus Document of the European Society of Cardiology Working Group on Thrombosis, EHRA, EAPCI, ACCA Endorsed by HRS and APHRS (DO NOT EDIT)[1] ==
General
Stable CAD
NSTE-ACS Including Unstable Angina and NSTEMI
Primary PCI
Application to General Anticoagulated Patients Who May or May Not Have AF
References
- ↑ Task Force Members. Lip GY, Windecker S, Huber K, Kirchhof P, Marin F; et al. (2014). "Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS)". Eur Heart J. doi:10.1093/eurheartj/ehu298. PMID 25154388.